These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 22855857)
21. Shang X; Bai H; Fan L; Zhang X; Zhao X; Liu Z Front Cell Infect Microbiol; 2024; 14():1387414. PubMed ID: 38751998 [TBL] [Abstract][Full Text] [Related]
22. Cationic amphiphiles against Gardnerella vaginalis resistant strains and bacterial vaginosis-associated pathogens. Weeks RM; Moretti A; Song S; Uhrich KE; Karlyshev AV; Chikindas ML Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31603505 [TBL] [Abstract][Full Text] [Related]
23. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model. Alves P; Castro J; Sousa C; Cereija TB; Cerca N J Infect Dis; 2014 Aug; 210(4):593-6. PubMed ID: 24596283 [TBL] [Abstract][Full Text] [Related]
24. Castro J; Rosca AS; Cools P; Vaneechoutte M; Cerca N Front Cell Infect Microbiol; 2020; 10():83. PubMed ID: 32195197 [TBL] [Abstract][Full Text] [Related]
26. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Verstraelen H; Swidsinski A Curr Opin Infect Dis; 2013 Feb; 26(1):86-9. PubMed ID: 23221767 [TBL] [Abstract][Full Text] [Related]
27. Lactobacillus crispatus represses vaginolysin expression by BV associated Gardnerella vaginalis and reduces cell cytotoxicity. Castro J; Martins AP; Rodrigues ME; Cerca N Anaerobe; 2018 Apr; 50():60-63. PubMed ID: 29427630 [TBL] [Abstract][Full Text] [Related]
28. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes. Patterson JL; Stull-Lane A; Girerd PH; Jefferson KK Microbiology (Reading); 2010 Feb; 156(Pt 2):392-399. PubMed ID: 19910411 [TBL] [Abstract][Full Text] [Related]
29. Drawing the line between commensal and pathogenic Gardnerella vaginalis through genome analysis and virulence studies. Harwich MD; Alves JM; Buck GA; Strauss JF; Patterson JL; Oki AT; Girerd PH; Jefferson KK BMC Genomics; 2010 Jun; 11():375. PubMed ID: 20540756 [TBL] [Abstract][Full Text] [Related]
30. BV and non-BV associated Gardnerella vaginalis establish similar synergistic interactions with other BV-associated microorganisms in dual-species biofilms. Castro J; Cerca N Anaerobe; 2015 Dec; 36():56-9. PubMed ID: 26505928 [TBL] [Abstract][Full Text] [Related]
31. The Effect of Lysozyme on Reducing Biofilms by Staphylococcus aureus, Pseudomonas aeruginosa, and Gardnerella vaginalis: An In Vitro Examination. Hukić M; Seljmo D; Ramovic A; Ibrišimović MA; Dogan S; Hukic J; Bojic EF Microb Drug Resist; 2018 May; 24(4):353-358. PubMed ID: 28922066 [TBL] [Abstract][Full Text] [Related]
32. Association between statin use, the vaginal microbiome, and Gardnerella vaginalis vaginolysin-mediated cytotoxicity. Abdelmaksoud AA; Girerd PH; Garcia EM; Brooks JP; Leftwich LM; Sheth NU; Bradley SP; Serrano MG; Fettweis JM; Huang B; Strauss JF; Buck GA; Jefferson KK PLoS One; 2017; 12(8):e0183765. PubMed ID: 28846702 [TBL] [Abstract][Full Text] [Related]
33. Vaginolysin drives epithelial ultrastructural responses to Gardnerella vaginalis. Randis TM; Zaklama J; LaRocca TJ; Los FC; Lewis EL; Desai P; Rampersaud R; Amaral FE; Ratner AJ Infect Immun; 2013 Dec; 81(12):4544-50. PubMed ID: 24082080 [TBL] [Abstract][Full Text] [Related]
34. Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus. Muli F; Struthers JK Antimicrob Agents Chemother; 1998 Jun; 42(6):1428-32. PubMed ID: 9624489 [TBL] [Abstract][Full Text] [Related]
35. Comparative transcriptomic analysis of Castro J; França A; Bradwell KR; Serrano MG; Jefferson KK; Cerca N NPJ Biofilms Microbiomes; 2017; 3():3. PubMed ID: 28649404 [TBL] [Abstract][Full Text] [Related]
36. Biotypes and virulence factors of Gardnerella vaginalis isolated from cases of bacterial vaginosis. Udayalaxmi J; Bhat GK; Kotigadde S Indian J Med Microbiol; 2011; 29(2):165-8. PubMed ID: 21654113 [TBL] [Abstract][Full Text] [Related]
37. The anti-HIV microbicide candidate RC-101 inhibits pathogenic vaginal bacteria without harming endogenous flora or mucosa. Eade CR; Cole AL; Diaz C; Rohan LC; Parniak MA; Marx P; Tarwater PM; Gupta P; Cole AM Am J Reprod Immunol; 2013 Feb; 69(2):150-8. PubMed ID: 23167830 [TBL] [Abstract][Full Text] [Related]
38. Growth inhibition of metronidazole-susceptible and metronidazole-resistant strains of Gardnerella vaginalis by Lactobacilli in vitro. McLean NW; McGroarty JA Appl Environ Microbiol; 1996 Mar; 62(3):1089-92. PubMed ID: 8975601 [TBL] [Abstract][Full Text] [Related]
39. Innate immune components affect growth and virulence traits of bacterial-vaginosis-associated and non-bacterial-vaginosis-associated Gardnerella vaginalis strains similarly. Castro J; Jefferson KK; Cerca N Pathog Dis; 2018 Dec; 76(9):. PubMed ID: 30649289 [TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of seaweed extracts on the growth of the vaginal bacterium Gardnerella vaginalis. Ha YM; Choi JS; Lee BB; Moon HE; Cho KK; Choi IS J Environ Biol; 2014 May; 35(3):537-42. PubMed ID: 24813010 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]